Market revenue in 2023 | USD 290.0 million |
Market revenue in 2030 | USD 479.9 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 79.66% in 2023. Horizon Databook has segmented the Japan real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
Growth in the market can be attributed to the increasing prevalence of target diseases, the growing awareness regarding early disease diagnosis, and the rising geriatric population. Japan has a well-established public healthcare system, trained public health workers, and enhanced healthcare services in educational centers.
These factors are contributing to the reduced mortality rate of infectious diseases. Moreover, the rising prevalence of infectious diseases is expected to impede economic and social advancement in Japan. Due to the increasing need for improved disease management, the market in Japan is expected to exhibit steady growth over the forecast period.
Moreover, researchers are engaged in the development of cheaper alternatives for the detection of diseases. Biohackers and the researchers at Keio University’s Institute of Advanced Life Sciences, with the collaboration of Tokyo BioClub, are developing a new real-time kit, Ninja qPCR, at a low cost of around USD 300.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into Japan real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account